Palbociclib and Letrozole in Advanced Breast CancerRichard S. Finn, Dennis J. Slamon, Sophia Randolph et al.|New England Journal of Medicine|2016Cited by 2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)Fátima Cardoso, Eric P. Winer, A. Costa et al.|Annals of Oncology|2016Cited by 2.1k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)Fátima Cardoso, E.P. Winer, Elżbieta Senkus et al.|Annals of Oncology|2018Cited by 1.2k
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised studyJavier Cortés, Chris Twelves, Joyce O’Shaughnessy et al.|The Lancet|2011Cited by 1.1k
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIAIan E. Krop, Véronique Dièras|Annals of Oncology|2014Cited by 401